One hundred children treated with tacrolimus after primary orthotopic liver transplantation

Transplant Proc. 1998 Jun;30(4):1397-8. doi: 10.1016/s0041-1345(98)00287-5.

Authors

S McDiarmid¹, J Goss, P Seu, C Shackleton, J Vargas, M Ament, R Busuttil

Affiliation

¹ Dumont-UCLA Liver Transplant Program, University of California 90095-1752, USA.

PMID: 9636564
DOI: 10.1016/s0041-1345(98)00287-5

No abstract available

MeSH terms

Child
Child, Preschool
Drug Administration Schedule
Follow-Up Studies
Graft Rejection / epidemiology
Graft Rejection / prevention & control
Graft Survival
Humans
Immunosuppressive Agents / therapeutic use*
Liver Transplantation / immunology*
Liver Transplantation / mortality
Lymphoproliferative Disorders / epidemiology
Methylprednisolone / therapeutic use
Muromonab-CD3 / therapeutic use
Mycophenolic Acid / analogs & derivatives
Mycophenolic Acid / therapeutic use
Postoperative Complications
Prednisone / therapeutic use
Retrospective Studies
Survival Rate
Tacrolimus / therapeutic use*
Time Factors

Substances

Immunosuppressive Agents
Muromonab-CD3
Mycophenolic Acid
Prednisone
Tacrolimus
Methylprednisolone